Hypoxia-mediated chromatin accessibility reprogramming of CA9 induces treatment resistance in colorectal mucinous adenocarcinoma
Journal of Gastroenterology · 24.06.2026
DOI: 10.1007/s00535-026-02461-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 24.06.2026. Verfasst von An Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: the Capital's Funds for Health Improvement and Research of China, the Young Investigator Training Program of The First Affiliated Hospital of Nanchang University, the Capital’s Funds for Health Improvement and Research of China.
Abstract (Originalsprache)
BACKGROUND: Mucinous adenocarcinoma (MAC) represents a subtype of colorectal cancer (CRC) characterized by insensitivity to chemoradiotherapy, necessitating urgent development of novel therapeutic strategies specifically targeting tumor biology of MAC. METHODS: Integrated analysis of ATAC-seq and RNA-seq data was performed to identify pivotal targets mediating treatment resistance in MAC. Subsequently, clinical specimens were collected for immunohistochemistry, RT-qPCR, and Kaplan-Meier survival analysis. Functional validation of the target was conducted through in vitro experiments encompassing colony formation, drug sensitivity assessments, synergy testing, and immunofluorescence. The translational potential of the target was evaluated in vivo. RESULTS: Integrated ATAC-seq and RNA-seq analyses identified hypoxia and dysregulated ferroptosis as critical features of MAC, screening carbonic anhydrase 9 (CA9) as a pivotal gene implicated in MAC treatment resistance. CA9-specific inhibitor synergized with 5-fluorouracil to exert enhanced antitumor effects. Additionally, CA9 knockdown or inhibition arrested tumor cell proliferation and migration, promoted intracellular reactive oxygen species generation, induced mitochondrial shrinkage, increased mitochondrial iron content, reduced glutathione levels, and triggered lipid peroxidation. Inhibitors of either ferroptosis or apoptosis antagonized CA9 inhibitor-mediated cell death. In vivo experiments demonstrated that CA9 knockdown or inhibition significantly delayed tumor growth. Co-immunoprecipitation revealed that CA9 interacts directly or indirectly with multiple ferroptosis-associated proteins. CONCLUSION: This study identifies the hypoxic tumor microenvironments and dysregulated ferroptosis as pivotal molecular characteristics of MAC, and proposes a novel mechanism underlying treatment resistance in MAC: Hypoxia remodels chromatin accessibility through epigenetic modifications, to dysregulate CA9 expression, which may subsequently modulate cellular susceptibility to ferroptosis, culminating in treatment resistance, and targeting CA9 may improve the therapeutic efficacy of MAC, although further studies are needed to establish direct causality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Department of General Surgery, Peking University First Hospital, Beijing, China.
- Department of Radiation Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing, China.
- Center for Precision Diagnosis and Treatment of Colorectal Cancer and Inflammatory Diseases, Peking University Health Science Center, Beijing, China.
- Department of Pancreas Surgery, Digestion and Vascular Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Förderung
- the Capital's Funds for Health Improvement and Research of China
- the Young Investigator Training Program of The First Affiliated Hospital of Nanchang University
- the Capital’s Funds for Health Improvement and Research of China
Zitieren
APA
Huang, A., Hong, H., Sun, Z., Gao, Z., Yang, Y., Chen, J., Sun, Y., Li, Z., Li, M., & Gu, J. (2026). Hypoxia-mediated chromatin accessibility reprogramming of CA9 induces treatment resistance in colorectal mucinous adenocarcinoma. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02461-x
Vancouver
Huang A, Hong H, Sun Z, Gao Z, Yang Y, Chen J, et al. Hypoxia-mediated chromatin accessibility reprogramming of CA9 induces treatment resistance in colorectal mucinous adenocarcinoma. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02461-x
BibTeX
@article{Huang2026,
author = {Huang, An and Hong, Haopeng and Sun, Zhuang and Gao, Zhaoya and Yang, Yong and Chen, Jiajia and Sun, Yonghui and Li, Zhengrong and Li, Ming and Gu, Jin},
title = {Hypoxia-mediated chromatin accessibility reprogramming of CA9 induces treatment resistance in colorectal mucinous adenocarcinoma},
journal = {Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s00535-026-02461-x}
}
EUVIMED